FDA Media Abbreviation: Janssen Vaccine COVID-19 | CDC Online Newsroom


A joint media release by the U.S. Centers for Disease Control and Prevention and U.S. Food and Drug Administration to discuss six reported cases of a rare blood type in individuals who received the Janssen COVID-19 Vaccine.

This media briefing will be live streamed on FDA YouTube page.


  • Peter Marks, MD, Ph.D., director of the FDA’s Center for Biologics Evaluation and Research
  • Anne Schuchat, MD, chief deputy director, CDC


Tuesday, Apr. 13 at 10:00 am ET


Callers in the United States or Canada can call 800-857-9789. International callers should dial 1-517-308-9484. The passcode for all participants was 7809201.

After the media briefing, a replay will be available on FDA YouTube page.

For other questions about the media briefing, please contact the FDA’s Office of Media Affairs at fdaoma@fda.hhs.gov.

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *